Ginkgo treatment for recent ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a concentrated form of ginkgo, given soon after an ischemic stroke (a stroke caused by a blocked blood vessel), can help improve recovery. It's only for people who start treatment within 48 hours of symptoms, so timing is critical.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older (any gender).
- Your stroke must have started within the last 48 hours.
- You (or a family member) must be able to give permission to take part, either in writing or by recorded verbal consent.
- You must have been able to live independently before this stroke (no significant disability).
- You cannot be taking any other ginkgo products or be in any other clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a ginkgo biloba extract supplement can help improve thinking and memory after a recent stroke. People who participate will receive the extract and have their cognitive function assessed with simple tests.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.
This study tests an investigational injectable drug called LT3001 that may help dissolve blood clots in the brain after a stroke. It is given within 24 hours of stroke onset, and the goal is to reduce disability and improve recovery.
This trial tests whether a medicine called an SGLT2 inhibitor, which is usually used for diabetes, can help protect the brain and improve recovery when given soon after a stroke. It is for people who had a stroke within the last 3 days and have moderate to severe symptoms.
This trial tests whether a drug called urinary kallidinogenase can help people who have had a stroke caused by a blocked artery in the brain. The drug is given within 48 hours of the stroke, and the study hopes to see if it improves recovery and reduces disability.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.